We are live on
!
Find out more
Asset Management One Portfolio holdings
AUM
$39B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.91%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.82%
5 Year Est. Return
+143.22%
10 Year Est. Return
+503.7%
AUM
$26.9B
AUM Growth
+$1.69B
(+6.7%)
Cap. Flow
-$340M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
25.25%
Holding
1,096
New
51
Increased
333
Reduced
625
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$77.4M |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$32.3M |
| 3 |
iShares MBS ETF
MBB
|
+$26.5M |
| 4 |
Caesars Entertainment
CZR
|
+$9.34M |
| 5 |
Charles River Laboratories
CRL
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$98.5M |
| 2 |
Apple
AAPL
|
+$36.1M |
| 3 |
Microsoft
MSFT
|
+$28.4M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$22.8M |
| 5 |
Amazon
AMZN
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.12% |
| 2 | Financials | 10.42% |
| 3 | Healthcare | 10.38% |
| 4 | Real Estate | 9.94% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Douglas Emmett
DEI
$1.99B
| $9.32M | 0.03% |
277,225
-8,802
| -3% | -$298K |
|
502
Burlington
BURL
$23.2B
| $9.3M | 0.03% |
28,893
-1,934
| -6% | -$616K |
|
|
HZNP
503
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $9.3M | 0.03% |
99,320
-3,584
| -3% | -$330K |
|
504
Lumen
LUMN
$6.65B
| $9.27M | 0.03% |
682,012
-113,986
| -14% | -$1.57M |
|
|
ONC
505
BeOne Medicines Ltd
ONC
$32.5B
| $9.26M | 0.03% |
26,983
-1,248
| -4% | -$413K |
|
506
Teleflex
TFX
$5.88B
| $9.21M | 0.03% |
22,934
-838
| -4% | -$343K |
|
507
Pool Corp
POOL
$6.79B
| $9.2M | 0.03% |
20,056
+1,981
| +11% | +$834K |
|
508
Park Hotels & Resorts
PK
$3.02B
| $9.18M | 0.03% |
445,610
+8,281
| +2% | +$177K |
|
509
Autoliv
ALV
$8.95B
| $9.12M | 0.03% |
93,333
+6,784
| +8% | +$684K |
|
510
Ally Financial
ALLY
$13.1B
| $9.09M | 0.03% |
182,394
+7,197
| +4% | +$369K |
|
511
Citizens Financial Group
CFG
$30.3B
| $9.06M | 0.03% |
197,524
-2,190
| -1% | -$103K |
|
512
HEICO Corp
HEI
$49.9B
| $9.02M | 0.03% |
64,708
+6,064
| +10% | +$837K |
|
513
Quest Diagnostics
DGX
$25.9B
| $8.98M | 0.03% |
68,084
-1,475
| -2% | -$193K |
|
514
Alnylam Pharmaceuticals
ALNY
$27.2B
| $8.97M | 0.03% |
52,946
-1,848
| -3% | -$271K |
|
|
EXAS
515
DELISTED
Exact Sciences
EXAS
| $8.96M | 0.03% |
72,076
+321
| +0.4% | +$38.3K |
|
|
WORK
516
DELISTED
Slack Technologies, Inc.
WORK
| $8.95M | 0.03% |
202,128
-7,406
| -4% | -$317K |
|
517
M&T Bank
MTB
$35.9B
| $8.93M | 0.03% |
61,469
-396
| -0.6% | -$61.9K |
|
|
CTLT
518
DELISTED
CATALENT, INC.
CTLT
| $8.91M | 0.03% |
82,394
+3,347
| +4% | +$359K |
|
519
Albemarle
ALB
$13.8B
| $8.91M | 0.03% |
52,869
+219
| +0.4% | +$35.3K |
|
520
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $8.9M | 0.03% |
163,953
-12,933
| -7% | -$689K |
|
|
521
Charles River Laboratories
CRL
$11.2B
| $8.86M | 0.03% |
23,948
+21,550
| +899% | +$7.2M |
|
522
Domino's
DPZ
$11.5B
| $8.85M | 0.03% |
18,974
-2,657
| -12% | -$1.13M |
|
523
Highwoods Properties
HIW
$3.66B
| $8.84M | 0.03% |
195,691
-3,949
| -2% | -$178K |
|
524
Cooper Companies
COO
$14B
| $8.83M | 0.03% |
89,176
-11,932
| -12% | -$1.17M |
|
525
Monolithic Power Systems
MPWR
$70B
| $8.82M | 0.03% |
23,615
+4,373
| +23% | +$1.54M |
|
Similar funds
Asset Management One's Q2 2021 Portfolio in Review
As of Q2 2021, Asset Management One held 1,096 positions worth $26.9B, up 6.7% from $25.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Asset Management One's Q2 2021 filing shows 51 new, 333 increased, 625 reduced and 52 closed positions. Its largest new stake was Bio-Techne: 67,900 shares worth $7.64M. The largest sale was Alibaba, an estimated $98.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Asset Management One's largest Q2 2021 buy was Bio-Techne: 67,900 shares worth $7.64M.
- Asset Management One added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2021, an estimated $77.4M increase.
- Asset Management One's biggest Q2 2021 reduction was Alibaba, cutting an estimated $98.5M.
- Asset Management One fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $11.1M.
- Asset Management One's ten largest holdings make up 25% of its $26.9B portfolio in Q2 2021.
- Asset Management One opened 51 new positions and closed 52 in Q2 2021.
- Asset Management One's portfolio value rose 6.7% quarter-over-quarter to $26.9B.
Based on Asset Management One's 13F filing for Q2 2021, filed 3 Aug 2021.